LM Advisors’s Pulse Biosciences PLSE Stock Holding History

LM Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,430	Closed	-$29.7K	–	583
2023 Q4	$29.7K	Buy	+2,430	New	+$16.8K	0.01%	383

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LM Advisors's PLSE Position: Q1 2024 in Review

LM Advisors sold out of Pulse Biosciences (PLSE) in Q1 2024, closing a stake of 2,430 shares — an estimated $29.7K sold.

LM Advisors first reported a position in PLSE in Q4 2023 and held it in 1 quarter. The position peaked at $29.7K in Q4 2023. 62 funds tracked by Wall St. Rank hold PLSE as of Q1 2024.

LM Advisors reported no remaining Pulse Biosciences position as of Q1 2024 after selling out during the quarter.
LM Advisors sold 2,430 Pulse Biosciences shares in Q1 2024, an estimated $29.7K.
LM Advisors first reported a position in Pulse Biosciences in Q4 2023 and held it in 1 quarter.
LM Advisors's Pulse Biosciences position peaked at $29.7K in Q4 2023.
62 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2024.

Based on LM Advisors's 13F filing for Q1 2024, filed 15 May 2024.